The Effect of Amantadine on Post-COVD-19 Fatigue

Clinical trial NCT05667077 · UNKNOWN

Trial details

NCT number: NCT05667077
Sponsor: Shahid Beheshti University of Medical Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Post-COVID-19 Syndrome

Start date: 2022-12-26
Primary completion: 2022-12-29
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.